Analysis of putative resistance mechanisms in recent treatments targeting the androgen receptor in castration-resistant prostate cancer (CRPC).
Paul Thelen
Honoraria - Janssen-Cilag
Other Remuneration - Janssen-Cilag
Eiko Walleck
No relevant relationships to disclose
Felix Bremmer
No relevant relationships to disclose
Lutz Trojan
Honoraria - Janssen-Cilag
Arne Strauß
Honoraria - Janssen-Cilag